Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 857-864

  Inoue, Hideyuki ^a   Yokoyama, Fumi ^a   Kita, Yuko ^a   Yoshiji, Hitoshi ^b   Tsujimoto, Tatsuhiro ^b   Deguchi, Akihiro ^a   Nakai, Seiji ^a   Morishita, Asahiro ^a   Uchida, Naohito ^a   Masaki, Tsutomu ^a   Watanabe, Seishiro ^a   Kuriyama, Shigeki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

c Met; Hepatocyte; Hepatocyte growth factor; Liver cirrhosis; Proliferating cell nuclear antigen; Proliferation; Real time reverse transcription polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLINE; DIMETHYLNITROSAMINE; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL; ARTICLE; BLOOD; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELL PROLIFERATION; DIMETHYLNITROSAMINE; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LIVER; LIVER CIRRHOSIS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 33750596495     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.857     Document Type: Article

References (54)

1. Yoneyama K, Taniguchi H, Kiuchi Y, Shibata M and Mitamura K: Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma. Scand J Gastroenterol 39: 1272-1279 2004. (Pubitemid 39656844)
2. Creutzfeldt W and Beck K: Cirrhosis of the liver. On the aetiology, pathogenesis, results of treatment and period of survival in an unselected series of 560 patients. Ger Med Mon 11: 259-265, 1966.
3. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
4. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
5. Sandal T: Molecular aspects of the mammalian cell cycle and cancer. Oncologist 7: 73-81, 2002.
6. Kita Y, Masaki T, Funakoshi F, Yoshida S, Tanaka M, Kurokohchi K, Uchida N, Watanabe S, Matsumoto K and Kuriyama S: Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats. Int J Oncol 24: 1205-1211, 2004.
7. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M and Kuriyama S: Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37: 534-543, 2003.
8. Masaki T, Morishita A, Nakai S, Uchida N, Kurokohchi K, Watanabe S and Kuriyama S: Cell cycle of hepatocellular carcinoma. In: New Perspectives in Cancer Research and Therapy. Kuriyama S and Yoshiji H (eds). Research Signpost, Kerala, India, pp183-190, 2005.
9. Morishita A, Masaki T, Yoshiji H, Nakai S, Ogi T, Miyauchi Y, Yoshida S, Funaki T, Uchida N, Kita Y, Funakoshi F, Usuki H, Okada S, Izuishi K, Watanabe S, Kurokohchi K and Kuriyama S: Reduced expression of cell cycle regulator p18INK4C in human hepatocellular carcinoma. Hepatology 40: 677-686, 2004.
10. Funakoshi F, Masaki T, Kita Y, Hitomi M, Kurokohchi K, Uchida N, Watanabe S, Yoshiji H and Kuriyama S: Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats. Int J Mol Med 13: 779-787, 2004.
11. Yuji J, Masaki T, Yoshida S, Kita Y, Feng H, Uchida N, Yoshiji H, Kitanaka A, Watanabe S, Kurokohchi K and Kuriyama S: Identification of p46 Shc expressed in the nuclei of hepatocytes with high proliferating activity: study of regenerating rat liver. Int J Mol Med 13: 721-728, 2004.
12. Yoshida S, Masaki T, Feng H, Yuji J, Miyauchi Y, Funaki T, Yoshiji H, Matsumoto K, Uchida N, Watanabe S, Kurokohchi K and Kuriyama S: Enhanced expression of adaptor molecule of p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats. Int J Oncol 25: 1089-1096, 2004.
13. Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K and Kuriyama S: Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis and normal liver. Int J Oncol 26: 661-671, 2005.
14. Michalopoulos GK: Liver regeneration: molecular mechanisms of growth control. FASEB J 4: 176-187, 1990.
15. Fausto N, Laird AD and Webber EM: Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 9: 1527-1536, 1995.
16. Fausto N: Liver regeneration. J Hepatol 32 (suppl 1): 19-31, 2002.
17. Hammond DE, Carter S and Clague MJ: Met receptor dynamics and signaling. Curr Top Microbiol Immunol 286: 21-44, 2004.
18. Sattler M, Ma PC and Salgia R: Therapeutic targeting of the receptor tyrosine kinase Met. Cancer Treat Res 119: 121-138, 2004.
19. Zarnegar R, De Frances MC, Kost DP, Lindroos P and Michalopoulos GK: Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 177: 559-565, 1991.
20. Kuriyama S, Tsujimoto T, Nakatani Y, Tsujinoue H, Yoshiji H, Mitoro A, Yamazaki M, Okuda H, Toyokawa Y, Nagao S, Nishiwaki I and Fukui H: Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo 13: 129-134, 1999.
21. Masaki T, Tokuda M, Fujimura T, Ohnishi M, Tai Y, Miyamoto K, Itano T, Matsui H, Watanabe S, Sogawa K, Yamada T, Konishi R, Nishioka M and Hatase O: Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Hepatology 20: 425-435, 1994.
22. Yamagata M, Masaki T, Okudaira T, Imai Y, Shiina S, Shiratori Y and Omata M: Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression. Hepatology 29: 1722-1729, 1999.
23. Wu JC, Merlino G and Fausto N: Establishment and characterization of differentiated, non-transformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci USA 91: 674-678, 1994.
24. Rhim JA, Sandgren EP, Degen JL, Palmiter RD and Brinster RL: Replacement of diseased mouse liver by hepatic cell transplantation. Science 263: 1149-1152, 1994.
25. Overturf K, Al-Dhalimy M, Ou CN, Finegold M and Grompe M: Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151: 1273-1280, 1997. (Pubitemid 27479757)
26. Weglarz TC, Degen JL and Sandgren EP: Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am J Pathol 157: 1963-1974, 2000.
27. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J and Bedossa P: Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 32: 327-332, 2001.
28. Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB and Theise ND: Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol 39: 357-364, 2003.
29. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P and Mallat A: Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 45: 605-628, 2005.
30. Fausto N: Liver regeneration and repair: hepatocytes, progenitor cells and stem cells. Hepatology 39: 1477-1487, 2004.
31. Bataller R and Brenner DA: Liver fibrosis. J Clin Invest 115: 209-218, 2005.
32. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS and Fukui H: Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32: 1248-1254, 2000.
33. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H and Fukui H: Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36: 850-860, 2002.
34. Yoshiji H, Kuriyama S and Fukui H: Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 23: 348-356, 2002.
35. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Imazu H, Yanase K, Kuriyama S and Fukui H: Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol 37: 22-30, 2002.
36. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Yamazaki M, Tsujinoue H, Imazu H, Masaki T and Fukui H: Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52: 1347-1354, 2003.
37. Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H and Fukui H: Combination of interferon-β and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development. Liver Int 25: 153-161, 2005.
38. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T and Higashio K: Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636-642, 1996.
39. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM and Benedetti A: Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23: 1189-1199, 1996.
40. Ueno T, Sujaku K, Tamaki S, Ogata R, Kin M, Nakamura T, Sakamoto M, Torimura T, Mitsuyama K, Sakisaka S, Sata M and Tanikawa K: OK-432 treatment increases matrix metalloproteinase- 9 production and improves dimethylnitrosamineinduced liver cirrhosis in rats. Int J Mol Med 3: 497-503, 1999.
41. Bravo R, Fey SJ, Bellatin J, Larsen PM, Arevalo J and Celis JE: Identification of a nuclear and a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp Cell Res 136: 311-319, 1981.
42. Mathews MB, Bernstein RM, Franza BR Jr and Garrels JI: Identity of the proliferating cell nuclear antigen and cyclin. Nature 309: 374-376, 1984.
43. Bravo R, Frank R, Blundell PA and McDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 326: 515-517, 1987.
44. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM and Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520, 1987.
45. Morris GF and Mathews MB: Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856-13864, 1989.
46. Garcia RL, Coltrera MD and Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134: 733-739, 1989.
47. Wolf HK and Michalopoulos GK: Hepatocyte regeneration in acute fulminant and non-fulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 15: 707-713, 1992.
48. Weisgerber UM, Boeing H, Nemitz R, Raedsch R and Waldherr R: Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium. Gut 34: 1587-1592, 1993.
49. Rudi J, Waldherr R, Raedsch R and Kommerell B: Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. J Hepatol 22: 43-49, 1995.
50. Hata J, Ikeda E, Uno H and Asano S: Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 50: 1461-1468, 2002.
51. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P and McCaughan GW: Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct ligated rat model of cirrhosis. Hepatology 26: 624-633, 1997.
52. D'Errico A, Fiorentino M, Ponzetto A, Daikuhara Y, Tsubouchi H, Brechot C, Scoazec JY and Grigioni WF: Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. Hepatology 24: 60-64, 1996.
53. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E and Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26: 81-89, 1997.
54. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E and Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230, 1999. (Pubitemid 29068532)